Poloxin-2
CAS No. 321695-37-8
Poloxin-2( —— )
Catalog No. M34116 CAS No. 321695-37-8
Poloxin-2 is a potent and selective Plk1 PBD inhibitor with anti-tumour activity that reduces the protein level of Plk1 in HeLa cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 532 | Get Quote |
|
| 5MG | 922 | Get Quote |
|
| 10MG | 1140 | Get Quote |
|
| 25MG | 1463 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 500MG | 4419 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePoloxin-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPoloxin-2 is a potent and selective Plk1 PBD inhibitor with anti-tumour activity that reduces the protein level of Plk1 in HeLa cells.
-
DescriptionPoloxin-2 is a potent and selective Plk1 PBD inhibitor with anti-tumour activity that reduces the protein level of Plk1 in HeLa cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPLK
-
RecptorPLK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number321695-37-8
-
Formula Weight269.3
-
Molecular FormulaC16H15NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(OC(=O)C1=C(C)C=CC=C1)=C2C(C)=CC(=O)C(C)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK-461364
A potent, selective, and reversible ATP-competitive PLK1 inhibitor with Ki of 2.2 nM.
-
LDC1267
LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).
-
Rigosertib sodium
Rigosertib sodium (ON 01910.Na) is a potent, non-ATP-competitive PLK1 inhibitor (IC50=9-10 nM).
Cart
sales@molnova.com